ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,079,635 | +1.8% | 114,313 | +16.0% | 0.01% | -16.7% |
| Q2 2023 | $3,025,302 | -20.8% | 98,511 | -7.4% | 0.01% | -33.3% |
| Q1 2023 | $3,819,820 | +156.7% | 106,411 | +182.7% | 0.01% | +125.0% |
| Q4 2022 | $1,487,766 | -61.9% | 37,646 | -61.2% | 0.00% | -81.0% |
| Q3 2022 | $3,902,000 | +266.4% | 97,079 | +289.3% | 0.02% | +320.0% |
| Q2 2022 | $1,065,000 | -31.3% | 24,935 | -29.1% | 0.01% | 0.0% |
| Q1 2022 | $1,550,000 | +75.1% | 35,184 | +55.7% | 0.01% | +66.7% |
| Q4 2021 | $885,000 | – | 22,595 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |